Cactus Pear Extract Shows Dual Action on Gut Health and Glucose Metabolism
An in vitro study examined how a standardized Opuntia ficus-indica (OFI) cladode and fruit peel extract, commercially branded RECOVERA®, behaves as it moves through the digestive system. Researchers used simulated digestion followed by colonic fermentation with fecal samples from 19 healthy adults (10 female, 9 male), then tested the extract’s bioavailable compounds on human skeletal muscle cells to measure metabolic effects.
Two phenolic compounds (piscidic acid and eucomic acid) survived digestion remarkably well, with over 80–90% remaining intact through the intestinal phase. When fermented by the stimulated microbiota, the extract drove significant increases in short-chain fatty acids (acetate, propionate, and butyrate) in both men and women, while shifting the microbiome toward more beneficial bacteria and away from potentially inflammatory strains. Notably, male and female microbiota responded differently, men produced relatively more propionate, women more butyrate, suggesting the extract works in alignment with natural sex-based differences in gut composition. Roughly 23% of the key phenolic compounds crossed the intestinal barrier, and these bioavailable fractions significantly enhanced glucose uptake and glycogen storage in muscle cells.
The findings point to a two-pronged mechanism: direct metabolic activity from the bioavailable phenolic acids, and indirect prebiotic effects via SCFA production. The study’s in vitro design means human clinical data is still needed to confirm these effects translate in the body. Overall, the branded OFI shows real promise as a functional ingredient bridging gut health, glycemic support, and muscle metabolism.
